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1 
Abstract 1 
Objective: Whether optimal cardiovascular health metrics may reduce the risk 2 
of cardiovascular events in secondary prevention is uncertain. The study was 3 
conducted to evaluate the influence of lifestyle changes on clinical outcomes 4 
among the subjects underwent percutaneous coronary intervention (PCI). 5 
Methods: The study group consists of 17,099 consecutive PCI patients. We 6 
recorded data on subject lifestyle behavior changes after their procedure. 7 
Patients were categorized as ideal, intermediate or poor CV health according 8 
to a modified Life’s Simple 7 score (on body mass, smoking, physical activity, 9 
diet, cholesterol, blood pressure and glucose). Multi-variable COX regression 10 
was used to evaluate the association between CV health and revascularization 11 
event. We also tested the impact of cumulative cardiovascular health score on 12 
re-occurrence of cardiovascular event. 13 
Results: During a 3-years median follow-up, 1,583 revascularization events 14 
were identified. The observed revascularization rate was 8.0%, 9.3% and 10.6% 15 
in the group of patients with optimal (modified-Life’s Simple 7 score of 11-14), 16 
average (score=9 or 10) or inadequate (less or equal than 8) CV health, 17 
respectively. After multivariable analysis, the adjusted hazard ratios were 0.83 18 
(95%CI: 0.73-0.94) and 0.89 (95%CI: 0.79-0.99) for patients with optimal and 19 
average lifestyle changes comparing with the inadequate tertile (P for 20 
trend=0.003). In addition, each unit increase in above metrics was associated 21 
with a decrease risk of revascularization (HR, 0.96; 95% confidence interval, 22 
 
2 
0.93-0.98; P<0.001). 1 
Conclusion: Ideal CV health related to lower incidence of cardiovascular 2 
events, even after the percutaneous coronary intervention. Revascularization 3 
can be reduced by lifestyle changes. The cardiovascular health metrics could 4 
be extrapolated to secondary prevention and need for further validation. 5 
 6 
Key Words: Cardiovascular health metrics, Secondary prevention, 7 
Revascularization 8 
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3 
Introduction 1 
Ideal cardiovascular health (CVH) has been proposed by the American 2 
Heart Association (AHA) and used to measure population health.1 The seven 3 
risk factors (Life’s Simple 7) that people can improve through lifestyle changes 4 
included four health behaviors (stop smoking, eat better, get active and lose 5 
weight) and three health factors (manage blood pressure, control cholesterol 6 
and reduce blood sugar). Cumulative evidence already demonstrated the AHA 7 
ideal CVH metrics could be used for cardiovascular health factors assessment, 8 
health promotion and a tool to predict mortality and cardiovascular diseases 9 
(CVD) risk.2,3 The steep gradient relationship between ideal CVH metrics and 10 
CVD was similar across different region and diverse race-ethnic groups.4-8 11 
The concept of ideal CVH metrics was originally defined and intended to 12 
use for primordial prevention among general population.1,9 Although the 13 
inverse relationship between ideal CVH and CVD incidence was also well 14 
documented for primary prevention,10-15 the evidence in secondary prevention 15 
is limited.16,17 It should be noticed that most of the individual components in 16 
ideal CVH metrics associated with reduced clinical event risk for the subject 17 
with established CVD.18,19 However, few data are available on the relationship 18 
between having ideal risk factor profile using a composite measure and the 19 
recurrence of cardiovascular events. 20 
Therefore, our aim in this study is to investigate the influence of ideal CVH 21 
as risk factor of cardiovascular outcomes for secondary prevention. The study 22 
 
4 
was based on a cohort of patients who underwent percutaneous coronary 1 
intervention. We hypothesized that the subjects with optimal CVH would be 2 
less likely to develop cardiovascular events during their follow-up period. 3 
 4 
Methods 5 
The data that support the findings of this study are available from the 6 
corresponding author upon reasonable request. 7 
 8 
Study design and population 9 
The current analysis was based on an established cohort from Fuwai 10 
hospital. A total of 19,506 consecutive patients with successful percutaneous 11 
coronary intervention were recruited. Further inclusion criteria for analysis 12 
were: subject should have at least one stent implantation, one year or longer 13 
post procedure follow up, alive, complete the questionnaire during follow-up 14 
visit. Finally, there were 17,099 (87.7%) patients fulfill the above requirements. 15 
The study protocol was approved by ethical committee and formal inform 16 
consent was obtained from every study participants. Details of the study 17 
design have been previously described.20 18 
 19 
Follow up 20 
Follow-up was conduct by a group of trained investigators. Standard 21 
operation procedure was fixed after a small scale pilot study. Non-responder 22 
 
5 
was the subject who can not be reached after 3 contacts on different days 1 
within one week. Both lifestyle changes related information and clinical 2 
outcomes were collected in a standardized questionnaire. A 5% random 3 
re-sampling process was carried out to validate the reliability of the data 4 
collected by the above interview procedure (kappa coefficients were from 0.91 5 
to 0.97 for different items in the questionnaire). 6 
 7 
Exposure and outcome 8 
Pre-specified options (exp. greater, no change or less) had been used to 9 
reflect the lifestyle behavior changes after PCI procedure compare with the 10 
situation before procedure. A modified Life’s Simple 7 score (on body mass, 11 
smoking, physical activity, diet, cholesterol, blood pressure and glucose) had 12 
been developed according to AHA recommendation (giving 2 points for ideal, 1 13 
point for intermediate and 0 point for poor). For physical activity, 2=longer, 14 
1=no change and 0=shorter. The blood pressure, cholesterol and glucose 15 
were used the same rule, 2=better controlled than before, 1=no change and 16 
0=worsen. Healthy diet covered fresh vegetables/fruits, salt and meat. If 17 
patient reported more fresh vegetables/fruits, less salt and meat consumption, 18 
the score for healthy diet was 2. On the opposite, if a patient had less 19 
vegetables/fruits, more salt or meat compare with before procedure status, the 20 
healthy diet score was 0. The remained situations were assigned 1 for diet 21 
score. For weight changes, 2=no change, 1=loss weight and 0=weight 22 
 
6 
increase. If patient was a non-smoker or they quit smoking at least 1 year 1 
before their procedure, the non-smoking score was 2. For smokers and other 2 
former smokers, the non-smoking score were 0 and 1 respectively. After obtain 3 
of the modified Life’s Simple 7 score, both cumulative score (ranged from 0 to 4 
14) and its tertiles (1st tertile: inadequate CVH, 2nd tertile: average CVH, 3rd 5 
tertile: optimal CVH) were used to estimate the impact on re-occurrence of 6 
cardiovascular event. The key clinical outcome in current analysis was any 7 
revascularization during the follow-up period. 8 
 9 
Statistical analysis 10 
Means and standard deviations were used as descriptive analysis for 11 
continuous variables. Categorical variables used frequencies and proportions. 12 
The patients were divided into 3 groups according to their tertiles of 13 
modified-Life’s Simple 7 score. One-way ANOVA or Chi-square test was used 14 
for between groups comparison where appropriate. To evaluate the potential 15 
association between modified-Life’s Simple 7 score and revascularization, the 16 
uni-variable and multi-variable COX regression model had been used. The 17 
covariates were fixed according to published literature (included demographic, 18 
health status, family health history and procedure related characteristics etc.). 19 
Firstly, the trend between each ideal CVH group had been tested. After that, 20 
dummy variables were used to represent the patient with optimal (11-14) and 21 
average (score=9 or 10) modified-Life’s Simple 7 score and the lowest tertile 22 
 
7 
(inadequate: socre less or equal than 8) group was used as reference. In 1 
addition, the risk of revascularization for each unit increase in ideal CVH 2 
metrics was estimated under the same confounding variables adjustment 3 
model. The analysis software was SAS®9.4 and significant level in this study 4 
was 2-sided 0.05. 5 
 6 
Results 7 
Characteristics of study population 8 
A total of 17,099 percutaneous coronary intervention patients (78.7% male) 9 
with a mean age of years 57.5±10.4 were enrolled in this analysis. Two-thirds 10 
of the patients were diagnosed as unstable ungina. The proportion of 11 
hypertension, dyslipidemia and diabetes among the overall population was 12 
50.0%, 32.0% and 18.5%, respectively. A total of 1,583 revascularization 13 
events during the follow-up period had been identified. The participants were 14 
grouped by the occurrence of revascularization (Yes/No). Detail demographic 15 
characteristics are listed in Table 1. 16 
 17 
Lifestyle behavior (ideal cardiovascular health metrics) changes 18 
Table 2 shows the prevalence of each component of cardiovascular health 19 
metrics. Most subjects (72.8%) could manage and maintain weight at 20 
appropriate range after their PCI procedure. More than half of the patients 21 
were non-smoker or permanent quit smoking. Over forty percent subjects 22 
 
8 
moved to a healthy diet behavior after their discharge from hospital. The 1 
control of blood pressure, cholesterol and blood glucose was achieved in 2 
59.5%, 55.7% and 22.1% among the overall participants, respectively. The 3 
proportions of each individual ideal CVH component among the tertile groups 4 
(determined by the cumulative score: inadequate, average and optimal) had 5 
also been described. 6 
 7 
Uni- and multi-variable logistic regression analysis 8 
Firstly, we simply counted the cumulative score of ideal Life’s Simple 7 9 
components. The hazard ratio of 1 unit change on the ideal CVH metrics was 10 
0.96 (95% CI, 0.93 to 0.98) after the adjustment of potential confounding 11 
variables. The multivariable COX regression model shows, comparing with the 12 
inadequate category (the lowest tertile on lifestyle behavior modification), the 13 
hazard ratios on revascularization for patients in average and optimal ideal 14 
CVH group were 0.89 (95% CI, 0.79 to 0.99) and 0.83 (95% CI, 0.73 to 0.94), 15 
respectively. The P for trend was 0.003. The relationships between each 16 
individual ideal CVH components and repeated revascularization event were 17 
ranged from 0.79 to 1.05 (hazard ratios by multivariable adjusted model). 18 
Detail results are described in Table 3. 19 
 20 
Discussion 21 
Key findings and study strengths 22 
 
9 
Our study suggested subjects in optimal ranges of Life’s Simple 7 (LS7) 1 
had a lower risk of revascularization compared with people in poor ranges 2 
during a 3 years follow-up period after percutaneous coronary intervention. 3 
Each additional ideal cardiovascular health metrics was associated with 4% 4 
lower risks of repeated revascularization event. To the best of our knowledge, 5 
this study is the first to investigate the association of ideal cardiovascular 6 
health metrics with clinical outcome among participants underwent 7 
percutaneous coronary intervention. 8 
 9 
Comparisons with published literature 10 
Current percutaneous coronary intervention studies are more focused on 11 
examining the efficacy of different treatment strategies, of emerging or existing 12 
devices and of the value of coronary physiology or intravascular imaging in 13 
PCI planning.21 Evidence regarding the links between healthy lifestyle and 14 
cardiometabolic consequences in people who had coronary interventions is 15 
fairly sparse. Potential benefit of Life’s Simple 7 had been investigated among 16 
myocardial infarction patients. The findings suggested ideal CV health at 17 
middle age was associated with better prognosis after MI in later life.22 18 
However, the impact of ideal cardiovascular health metrics among subjects 19 
with different risk strata has not been well established. In a recent large scale 20 
nationwide prospective cohort study, participants with prediabetes or diabetes 21 
who had five or more ICVHMs (ideal cardiovascular health metrics) exhibited 22 
 
10 
lower or no significant excess risk of CVD events compare with those with 1 
normal glucose regulation. Compared with 1 ideal CVH metric or none, 5 or 2 
more ideal metrics were associated with 58% and 61% lower CVD risks 3 
among participants with prediabetes and diabetes, respectively.23 The 4 
attenuated effect size observed in our study may attribute to the heterogeneity 5 
between different populations. Our study extends previous findings by 6 
comprehensively assessing 7 lifestyle risk factors in secondary prevention for 7 
revascularization in relation to lifestyle factors individually and in combination. 8 
Baseline measurement of ideal CVH and the longitudinal maintenance of 9 
CVH were both significant associated with CVD progression in general 10 
population.24,25 However, it should be noticed the prevalence of ideal 11 
cardiovascular health metrics was systematic different in secondary 12 
prevention.26 For example, the prevalence of smoking in general population 13 
has been reported to be 52.9%.27 But the proportion for quit smoking was only 14 
8%.28 In contrast, the smoking cessation rate was 40% to 94% at 1 year and 15 
37% at 5 years after the ischemic event.29,30 Further, a pooled cohorts 16 
consisted of 661,137 participants indicate a benefit threshold at approximately 17 
3 to 5 times the recommended leisure time physical activity.31 Around one fifth 18 
participants could meet the above intensity of physical activity for general 19 
population. Compare with our study, the observed proportion of patient had 20 
increased level of physical activities after the PCI procedure was around thirty 21 
percent (27.7%). Cardiovascular intervention is an opportunity to reassess the 22 
 
11 
risk factor control and an optimal time when patients and family members are 1 
more likely to be receptive to lifestyle modification.32 Healthcare professionals 2 
should encourage PCI patient to perform more ideal CVH metrics. 3 
Although cardiac rehabilitation is strongly recommended following 4 
myocardial infarction, which components of rehabilitation are most beneficial is 5 
unclear.33 As one key component of cardiovascular health metrics, smoking 6 
increases the risk of virtually all cardiovascular disease subtypes.34 Smoking 7 
cessation had been demonstrated as a modifiable risk factor both for primary 8 
and secondary prevention of stroke.35-37 However, the effect of single ideal 9 
CVH metrics maybe partly attributable to other lifestyle behavior changes (eg. 10 
subject has more exercise and healthier diet at the same time with smoking 11 
cessation).36,38 The combination of cardiovascular health metrics may had joint 12 
impact on the endothelialization and inflammatory process. This proposed 13 
phenomenon was corresponding to the underling mechanism of restenosis of 14 
the coronary arteries.39,40 Further basic researches are required to validate the 15 
above hypothesis. 16 
 17 
Study limitations 18 
Our study has several limitations. First, we could not fully rule out all the 19 
residual and unmeasured confounders, such as genetic predisposition, 20 
medications, and psychological status and possible reverse causation. 21 
Nevertheless, the sensitivity analysis taking into account this potential bias 22 
 
12 
showed similar results. Second, the cardiovascular health metrics were 1 
modified according to the feature of follow-up process in this study. The 2 
changes in the metrics over time (health check-up periods) could not be 3 
accounted for in this study. Further, participants were excluded if their 4 
cardiovascular health metrics missing, so the selection bias may also exist. 5 
Third, measurement errors in self-reported assessments of lifestyle changes 6 
were inevitable, although the accuracy of self-reports information had been 7 
demonstrated through a 5% re-sampling validation process. The use of 8 
prospectively collected, cumulatively averaged values based repeated 9 
assessments would be reduced the effect of random measurement error. By 10 
the above reasons our results should be interpreted cautiously. 11 
 12 
Conclusions 13 
In this observational study, patients underwent percutaneous coronary 14 
intervention who achieved a greater number of ideal CVH metrics exhibited 15 
lower risk of repeated revascularization event. Our findings emphasize the 16 
importance of promoting the adherence to ideal CVH metrics in the population 17 
with established cardiovascular disease. We believe further researches 18 
addressing this hypothesis are warranted. 19 
  20 
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Table 1 Baseline Characteristics of Participant with or without 1 
Revascularization 2 
Variables 
Revas. 
(N=1583) 
No Revas. 
(N=15516) 
P value 
Age, y, mean±SD 58.1±10.4 57.4±10.4 0.023 
Male, n (%) 1259 (79.5) 12201 (78.6) 0.406 
Unstable angina, n (%) 1028 (64.9) 10228 (65.9) <0.001 
Prior myocardial Infarction, n (%) 570 (36.0) 4755 (30.7) <0.001 
Family history of CHD, n (%) 88 (5.6) 611 (3.9) 0.002 
Hypertension, n (%) 911 (57.6) 7636 (49.2) <0.001 
Dyslipidemia, n (%) 574 (36.3) 4905 (31.6) <0.001 
Diabetes, n (%) 349 (22.1) 2821 (18.2) <0.001 
LVEF<40%, n (%) 683 (43.2) 8516 (54.9) <0.001 
Reference Vessel Diameter, mm, 
mean±SD 
3.1±0.6 3.2±1.9 <0.001 
Lesion length, mm, mean±SD 26.1±15.7 25.4±14.6 0.078 
Diameter Stenosis, %, mean±SD 89.7±7.7 88.4±8.0 <0.001 
Calcification, n (%) 72 (4.6) 534 (3.4) 0.023 
Total occlusion, n (%) 469 (29.6) 3231 (20.8) <0.001 
Trans-radial access, n (%) 1140 (72.0) 12495 (80.5) <0.001 
TIMI classification, n (%)   <0.001 
0 421 (26.6) 3232 (20.8)  
1 75 (4.7) 648 (4.2)  
2 202 (12.8) 1945 (12.5)  
3 885 (55.9) 9691 (62.5)  
  3 
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Table 2 Prevalence of Ideal Cardiovascular Health Metrics 1 
 Overall 
(N=17099) 
Inadequate 
(N=5267) 
Average 
(N=6029) 
Optimal 
(N=5803) 
Physical activity 
-Poor 2785 (16.3) 1521 (28.9) 907 (15.0) 357 2.8) 
-Intermediate 9674 (56.0) 3254 (61.8) 3775 (62.6) 2545 (26.6) 
-Ideal 4740 (27.7) 492 (9.3) 1347 (22.3) 2901 (61.2) 
Blood pressure 
-Poor 1290 (7.5) 1000 (19.0) 250 (4.2) 40 (0.7) 
-Intermediate 5642 (33.0) 3150 (59.8) 2179 (36.1) 313 (5.4) 
-Ideal 10167 (59.5) 1117 (21.2) 3600 (59.7) 5450 (93.9) 
Blood cholesterol 
-Poor 1371 (8.0) 1003 (19.0) 315 (5.2) 53 (0.9) 
-Intermediate 6205 (36.3) 3348 (63.6) 2446 (40.6) 411 (7.1) 
-Ideal 9523 (55.7) 916 (17.4) 3268 (54.2) 5339 (92.0) 
Blood glucose 
-Poor 1977 (11.6) 1179 (22.4) 621 (10.3) 177 (3.1) 
-Intermediate 11337 (66.3) 3751 (71.2) 4525 (75.1) 3061 (52.8) 
-Ideal 3785 (22.1) 337 (6.4) 883 (14.7) 2565 (44.2) 
Ideal BMI 
-Poor 2046 (12.0) 1098 (20.9) 700 (11.6) 248 (4.3) 
-Intermediate 2599 (15.2) 1027 (19.5) 877 (14.6) 695 (12.0) 
-Ideal 12454 (72.8) 3142 (58.7) 4452 (73.8) 4860 (83.6) 
Healthy diet 
-Poor 818 (4.8) 543 (10.3) 207 (3.4) 68 (1.2) 
-Intermediate 9035 (52.8) 3720 (70.6) 3592 (59.6) 1723 (29.7) 
-Ideal 7246 (42.4) 1004 (19.1) 2230 (37.0) 4012 (69.1) 
Ideal smoking status 
-Poor 3683 (21.5) 2003 (38.0) 1190 (19.7) 490 (8.4) 
-Intermediate 4156 (24.3) 1557 (29.6) 1420 (23.6) 1179 (20.3) 
-Ideal 9260 (54.2) 1707 (32.4) 3419 (56.7) 4134 (71.2) 
  2 
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Table 3 Hazard Ration (95% CI) of Revascularization According to 1 
Combined and Individual Ideal CVH Metrics 2 
 Univariable 
analysis 
Multivariable 
analysis 
Combined ideal CVH metrics 
 - 1 unit change (Each 1-number 
increment in ICVHMs) 
0.95 (0.93, 0.98) 0.96 (0.93, 0.98) 
 - Trend (P for trend instead) 0.90 (0.85, 0.96) 
<0.001 
0.91 (0.85, 0.97) 
0.003 
 - Average vs. Inadequate 0.88 (0.79, 0.99) 0.89 (0.79, 0.99) 
 - Optimal vs. Inadequate 0.81 (0.72, 0.92) 0.83 (0.73, 0.94) 
Individual component of ideal CVH metrics – Physical activity 
 - 1 unit change 0.92 (0.85, 0.99) 0.92 (0.85, 0.99) 
 - P for trend 0.038 0.037 
Individual component of ideal CVH metrics - Blood pressure 
 - 1 unit change 0.89 (0.82, 0.96) 0.90 (0.84, 0.97) 
 - P for trend 0.002 0.008 
Individual component of ideal CVH metrics - Blood cholesterol 
 - 1 unit change 0.88 (0.82, 0.95) 0.89 (0.83, 0.96) 
 - P for trend 0.001 0.004 
Individual component of ideal CVH metrics - Blood glucose 
 - 1 unit change 0.79 (0.72, 0.86) 0.79 (0.72, 0.86) 
 - P for trend <0.001 <0.001 
Individual component of ideal CVH metrics - Ideal BMI 
 - 1 unit change 0.95 (0.89, 1.02) 0.94 (0.88, 1.01) 
 - P for trend 0.192 0.110 
Individual component of ideal CVH metrics - Healthy diet 
 - 1 unit change 0.98 (0.90, 1.06) 1.01 (0.92, 1.10) 
 - P for trend 0.586 0.885 
Individual component of ideal CVH metrics - Ideal smoking status 
 - 1 unit change 1.05 (0.98, 1.11) 1.05 (0.98, 1.12) 
 - P for trend 0.153 0.150 
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